These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10779030)

  • 21. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events.
    Ishitsuka K; Yokoyama Y; Baba N; Matsuoka R; Sakamoto N; Sakamoto T; Kusakabe M; Kato T; Kurita N; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    J Clin Exp Hematop; 2022 Sep; 62(3):154-157. PubMed ID: 35831099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma.
    Barta SK; Yahalom J; Shia J; Hamlin PA
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):77-82. PubMed ID: 16879775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vanishing bile duct syndrome and immunodeficiency preceding the diagnosis of Hodgkin lymphoma.
    Yeh P; Lokan J; Anantharajah A; Grigg A
    Intern Med J; 2014 Dec; 44(12a):1240-4. PubMed ID: 25442758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin's lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure.
    Fong M; Boyle S; Gutta N
    BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30796069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma].
    Han WS; Jung ES; Kim YH; Kim CH; Park SC; Lee JY; Chang YJ; Yeon JE; Byun KS; Lee CH
    Korean J Hepatol; 2005 Jun; 11(2):164-8. PubMed ID: 15980675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis.
    Moradpour D; Altorfer J; Flury R; Greminger P; Meyenberger C; Jost R; Schmid M
    Hepatology; 1994 Dec; 20(6):1437-41. PubMed ID: 7982642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vanishing bile duct syndrome-related jaundice as the first presentation of Hodgkin lymphoma.
    Mellat-Ardakani M; Salahshour F; Rafsanjani K; Avanaki FA; Azizi M
    Radiol Case Rep; 2023 Sep; 18(9):3291-3294. PubMed ID: 37483375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rare presentation of vanishing bile duct syndrome in Hodgkin lymphoma: Case report.
    Patodiya B; Ramani VK; Rao PN; Sharma M; Patodiya S; Reddy DN
    SAGE Open Med Case Rep; 2023; 11():2050313X231208968. PubMed ID: 37954540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.
    Pass AK; McLin VA; Rushton JR; Kearney DL; Hastings CA; Margolin JF
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):976-80. PubMed ID: 19131796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.
    Rota Scalabrini D; Caravelli D; Carnevale Schianca F; D'Ambrosio L; Tolomeo F; Boccone P; Manca A; De Rosa G; Nuzzo A; Aglietta M; Grignani G
    BMC Res Notes; 2014 Aug; 7():529. PubMed ID: 25125318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review.
    Wong KM; Chang CS; Wu CC; Yin HL
    Kaohsiung J Med Sci; 2013 Nov; 29(11):636-41. PubMed ID: 24183359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma - pathological development and restitution.
    Hallén K; Sangfelt P; Nilsson T; Nordgren H; Wanders A; Molin D
    Acta Oncol; 2014 Sep; 53(9):1271-5. PubMed ID: 24697745
    [No Abstract]   [Full Text] [Related]  

  • 36. Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease.
    Gottrand F; Cullu F; Mazingue F; Nelken B; Lecomte-Houcke M; Farriaux JP
    J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):430-3. PubMed ID: 9144127
    [No Abstract]   [Full Text] [Related]  

  • 37. L-carbocisteine can cause cholestasis with vanishing bile duct syndrome in children: A case report.
    Takaki Y; Murahashi M; Honda K; Hirai K
    Medicine (Baltimore); 2022 Nov; 101(45):e31486. PubMed ID: 36397354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholestatic syndrome as a presentation of non-Hodgkin lymphoma. A pediatric case report.
    Rojas Ortiz MV; Queizan L; Moscato J; Sarmiento E; Salgueiro F
    Arch Argent Pediatr; 2023 Aug; 121(4):e202202762. PubMed ID: 36705982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome.
    Cho HJ; Jwa HJ; Kim KS; Gang DY; Kim JY
    Pediatr Gastroenterol Hepatol Nutr; 2013 Dec; 16(4):273-8. PubMed ID: 24511525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Febrile cholestatic disease as an initial presentation of nodular lymphocyte-predominant Hodgkin lymphoma.
    Mrzljak A; Gasparov S; Kardum-Skelin I; Colic-Cvrlje V; Ostojic-Kolonic S
    World J Gastroenterol; 2010 Sep; 16(35):4491-3. PubMed ID: 20845519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.